Predictive Oncology approves 1-for-15 reverse stock split to meet Nasdaq bid price

Axe Compute Inc.

Stockholders approved 1:15 reverse split on Sep 19, 2025; effective Sep 30, 2025.
Post-split shares ~762,414, down from 11,436,201; fractional shares rounded up.
Split intended to bring POAI into compliance with Nasdaq minimum bid price requirement.
Standby Equity Purchase Agreement to issue up to $10M in common stock also approved by shareholders.

item 3.03item 5.03item 5.07item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.